Mountain View, CA, United States of America

Prabha N Ibrahim

USPTO Granted Patents = 134 

 

 

Average Co-Inventor Count = 5.0

ph-index = 42

Forward Citations = 3,960(Granted Patents)


Inventors with similar research interests:


Location History:

  • San Mateo, CA (US) (2020 - 2023)
  • Mountainview, CA (US) (2001 - 2024)

Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
Loading Chart...
134 patents (USPTO):

Title: Prabha N Ibrahim: A Prominent Innovator in Kinase Modulation

Introduction:

Meet Prabha N Ibrahim, a highly accomplished innovator and inventor based in Mountain View, CA. With an impressive track record of 126 patents to his name, Ibrahim has made significant contributions to the field of kinase modulation. This article delves into his latest patents, career highlights, notable collaborations, and underscores his valuable contributions to the scientific community.

Latest Patents:

Ibrahim's recent patents demonstrate his expertise in developing compounds and methods for kinase modulation. One of his latest patents focuses on "Compounds and methods for kinase modulation, and indications therefor." This patent describes the discovery and utilization of compounds that target protein kinases to address diseases and conditions associated with aberrant kinase activity. By developing novel compounds and treatment methods, Ibrahim has showcased his commitment to advancing healthcare innovation.

Another notable recent patent by Ibrahim is titled "Formulations of a compound modulating kinases." This patent elaborates on the development of solid dispersions containing a specific compound, referred to as Compound I. These solid dispersions are substantially amorphous and have demonstrated potential for various applications. The patent encompasses methods of manufacturing these formulations and their subsequent use in healthcare.

Career Highlights:

Throughout his career, Prabha N Ibrahim has held influential positions in several renowned companies. Two notable companies where he has excelled are Plexxikon Inc. and CV Therapeutics, Inc. (co-written as "CV Therapeutics, Inc.").

Collaborations:

Ibrahim has collaborated with esteemed colleagues, some of whom include Chao Zhang and Jiazhong Zhang. These collaborations have fostered groundbreaking research and the development of innovative solutions in kinase modulation. By sharing expertise and working together, Ibrahim and his coworkers have contributed to advancements in the field.

Conclusion:

Prabha N Ibrahim's remarkable achievements in the realm of kinase modulation have solidified his reputation as an esteemed inventor and innovator. His patents on compounds and methods for kinase modulation exemplify his commitment to addressing diseases and conditions associated with aberrant kinase activity. Ibrahim's contributions have not only advanced scientific knowledge but have also paved the way for the development of potential treatments that can make a difference in patients' lives. The collaborative efforts with talented individuals such as Chao Zhang and Jiazhong Zhang further underscore his commitment to generating impactful innovations.

For more information on Prabha N Ibrahim's patents, career, and significant contributions, please visit our website idiyas.com, dedicated to exploring innovations, inventions, and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…